camptothecin has been researched along with dichlororibofuranosylbenzimidazole in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (10.00) | 18.7374 |
1990's | 6 (60.00) | 18.2507 |
2000's | 2 (20.00) | 29.6817 |
2010's | 1 (10.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bader, SB; Calderwood, SK; Mannheim-Rodman, LA; Price, BD | 1 |
Beardmore, C; D'Arpa, P; Liu, LF | 1 |
Kaufmann, SH | 1 |
Eskin, A; Koumenis, C; Nunez-Regueiro, M; Raju, U | 1 |
Adam, SA; Choi, YD; Dreyfuss, G | 1 |
Buckwalter, CA; Cheng, YC; Kaufmann, SH; Lin, AH; Pommier, YG; Tanizawa, A | 1 |
Ljungman, M | 1 |
Pandolfi, PP; Rasheed, ZA; Ravee, Y; Rubin, EH; Saleem, A | 1 |
Bonner, WM; Conti, C; Das, BB; Douarre, C; Guirouilh-Barbat, J; Kohn, KW; Nakamura, AJ; Nicolas, E; Pommier, Y; Redon, CE; Smith, S; Solier, S; Sordet, O | 1 |
Knox, AA; Turner, AJ; Watkins, NJ | 1 |
10 other study(ies) available for camptothecin and dichlororibofuranosylbenzimidazole
Article | Year |
---|---|
Inhibition of heat shock gene expression does not block the development of thermotolerance.
Topics: 3T3 Cells; Animals; Blotting, Northern; Camptothecin; Dichlororibofuranosylbenzimidazole; Electrophoresis, Polyacrylamide Gel; Gene Expression; Heat-Shock Proteins; Mice; RNA, Messenger; Temperature; Transcription, Genetic | 1992 |
Involvement of nucleic acid synthesis in cell killing mechanisms of topoisomerase poisons.
Topics: Amsacrine; Animals; Antibiotics, Antineoplastic; Aphidicolin; Camptothecin; Cell Survival; Cricetinae; Cricetulus; Cycloheximide; Deoxyadenosines; Dichlororibofuranosylbenzimidazole; Diterpenes; DNA; Etoposide; Mutagens; Nucleic Acids; RNA; Time Factors; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors | 1990 |
Antagonism between camptothecin and topoisomerase II-directed chemotherapeutic agents in a human leukemia cell line.
Topics: Amsacrine; Aphidicolin; Blotting, Western; Camptothecin; Colony-Forming Units Assay; Cycloheximide; Daunorubicin; Deoxyadenosines; Dichlororibofuranosylbenzimidazole; Diterpenes; DNA Polymerase II; DNA Replication; Drug Synergism; Etoposide; Female; Humans; Leukemia, Promyelocytic, Acute; Mutagens; RNA; Topoisomerase II Inhibitors; Topotecan; Tumor Cells, Cultured | 1991 |
Alteration of the phase and period of a circadian oscillator by a reversible transcription inhibitor.
Topics: Animals; Aplysia; Camptothecin; Circadian Rhythm; Dichlororibofuranosylbenzimidazole; Eye; In Vitro Techniques; Ocular Physiological Phenomena; Time Factors; Transcription, Genetic; Uridine | 1991 |
Physical change in cytoplasmic messenger ribonucleoproteins in cells treated with inhibitors of mRNA transcription.
Topics: Camptothecin; Dactinomycin; Dichlororibofuranosylbenzimidazole; Emetine; HeLa Cells; Humans; Kinetics; Molecular Weight; Neoplasm Proteins; Protein Biosynthesis; Ribonucleoproteins; Ribonucleosides; RNA, Messenger; Transcription, Genetic; Ultraviolet Rays | 1984 |
RNA synthesis inhibitors alter the subnuclear distribution of DNA topoisomerase I.
Topics: Animals; Camptothecin; Cell Nucleus; Cricetinae; Dichlororibofuranosylbenzimidazole; DNA Topoisomerases, Type I; Humans; Mice; RNA; Topotecan; Tumor Cells, Cultured | 1996 |
Effect of differential gene expression on the chromatin structure of the DHFR gene domain in vivo.
Topics: Animals; Camptothecin; CHO Cells; Chromatin; Cricetinae; Cross-Linking Reagents; Dichlororibofuranosylbenzimidazole; DNA; Furocoumarins; Gene Expression Regulation; Protein Conformation; Tetrahydrofolate Dehydrogenase; Thionucleotides | 1996 |
The topoisomerase I-binding RING protein, topors, is associated with promyelocytic leukemia nuclear bodies.
Topics: Amino Acid Sequence; Animals; Binding Sites; Camptothecin; Carrier Proteins; Cell Nucleus; Chromosome Mapping; Dichlororibofuranosylbenzimidazole; Dimethyl Sulfoxide; DNA Topoisomerases, Type I; DNA-Binding Proteins; HeLa Cells; Humans; Leukemia, Promyelocytic, Acute; Mice; Molecular Sequence Data; Neoplasm Proteins; Nuclear Proteins; Nucleic Acid Synthesis Inhibitors; Promyelocytic Leukemia Protein; Rabbits; Recombinant Fusion Proteins; Sequence Homology, Amino Acid; Topoisomerase I Inhibitors; Transcription Factors; Tumor Suppressor Proteins; Ubiquitin-Protein Ligases; Zinc Fingers | 2002 |
Ataxia telangiectasia mutated activation by transcription- and topoisomerase I-induced DNA double-strand breaks.
Topics: Adaptor Proteins, Signal Transducing; Alpha-Amanitin; Animals; Ataxia Telangiectasia Mutated Proteins; Camptothecin; Cell Cycle Proteins; Cells, Cultured; Dichlororibofuranosylbenzimidazole; DNA Breaks, Double-Stranded; DNA Topoisomerases, Type I; DNA-Binding Proteins; Enzyme Inhibitors; Flow Cytometry; Histones; Humans; Intracellular Signaling Peptides and Proteins; Lymphocytes; Microscopy, Confocal; Microscopy, Fluorescence; Neurons; Nuclear Proteins; Nucleic Acid Synthesis Inhibitors; Protein Serine-Threonine Kinases; Rats; Ribonuclease H; Signal Transduction; Trans-Activators; Transcription, Genetic; Tumor Suppressor p53-Binding Protein 1; Tumor Suppressor Proteins | 2009 |
Nucleolar disruption leads to the spatial separation of key 18S rRNA processing factors.
Topics: Camptothecin; Cell Nucleolus; Dactinomycin; Dichlororibofuranosylbenzimidazole; HeLa Cells; Humans; Nuclear Proteins; Nucleic Acid Synthesis Inhibitors; Protein Binding; Protein Synthesis Inhibitors; Protein Transport; Ribonucleoproteins, Small Nucleolar; RNA Polymerase I; RNA, Ribosomal, 18S; Topoisomerase I Inhibitors; Transcription, Genetic | 2012 |